Frequent Links
Chronic diseasesfood chemistry innovationsmusculoskeletal disorders journalsHIV and Cardiovascular DiseasesEvolutionary ComputationFree Online Peer Reviewed Pharmacovigilance JournalsSlippage - JournalsLoop AlgebraProduct formation kineticsVaccine immunologygene polymorphismMicrobial infection peer reviewed journalsMicrobial TechnologyYogaMinisequencing Open Access Journals
5,6-MDO-DiPT
| 200px | ||
| colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other This page is a soft redirect. Names #REDIRECTmw:Help:Magic words#Other
|
Other names
5,6-Methylenedioxy-N,N-diisopropyltryptamine
| |
|---|---|---|
| colspan=2 style="background:#f8eaba; border-top:2px solid transparent; border-bottom:2px solid transparent; text-align:center;" #REDIRECTmw:Help:Magic words#Other This page is a soft redirect. Properties #REDIRECTmw:Help:Magic words#Other |
C17H24N2O2 | |
| Molar mass | Lua error in Module:Math at line 495: attempt to index field 'ParserFunctions' (a nil value). g·mol−1 | |
| Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | ||
| 14px verify (what is: 10px/10px?) | ||
| Infobox references | ||
5,6-MDO-DiPT, or 5,6-methylenedioxy-N,N-diisopropyltryptamine, is a lesser-known psychedelic drug. It is the 5,6-methylenedioxy analog of DiPT. 5,6-MDO-DiPT was first synthesized by Alexander Shulgin. It is mentioned in his book TiHKAL (Tryptamines I Have Known and Loved), but 5,6-MDO-DiPT was never tested to determine what effects it produces, if any. Very little data exists about the pharmacological properties, metabolism, and toxicity of 5,6-MDO-DiPT.
See also
External links
Lua error in package.lua at line 80: module 'Module:Buffer' not found.